TCG Crossover Management »

Avalo Therapeutics Ord shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Avalo Therapeutics Ord

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 294M4.5M482.999k482.9995k483k483.0005k483.001k
Value ($)Share countHistorical AVTX position of TCG Crossover Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.6M 483k 7.43
2024-09-30 $4.6M 483k 9.50

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Xencor Comm (XNCR)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Ocular Therapeutix Comm (OCUL)
Upstream Bio Comm
Abivax Sa American Depositary Shares Adrs (ABVX)
Savara Comm (SVRA)
Tango Therapeutics Comm (TNGX)
Dianthus Therapeutics Comm (DNTH)
Disc Medicine Comm (IRON)
Mineralys Therapeutics Comm (MLYS)
Tourmaline Bio Comm (TRML)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Avalo Therapeutics Ord

BVF
Ikarian Capital
RA Capital Management
OrbiMed Advisors
Deep Track Capital
Affinity Asset Advisors
Commodore Capital
TCG Crossover Management
Vanguard Group
Boothbay Fund Management
BlackRock
Royal Bank of Canada
Geode Capital Management
UBS Group
Sio Capital Management

View all funds holding Avalo Therapeutics Ord